ArticleFrontiers in oncology2022

WASF2 Serves as a Potential Biomarker and Therapeutic Target in Ovarian Cancer: A Pan-Cancer Analysis.

Xiaofeng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.